Antioxidant Supplements: A Promising Approach to improving COVID-19 Demonstrations
Authors
Abstract:
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) that causes COVID-19 could progress to acute respiratory distress syndrome (ARDS). The immune cells' migration in response to virus lead to cell death by releasing oxidizing free radicals. These oxidizing free radicals mediate NF-κB activation and induce transcription of cytokine-producing genes that eventually a cytokine storm ensues, leading to septic shock. The over-expression of oxidative stress and enhancing ROS and RNS production activates transcription factors like NF-κB, so repeating this cycle intensifies the host inflammatory responses. In this way, antioxidants as compounds that inhibit oxidation by terminating chain reactions are suggested for alleviating the COVID-19 demonstration. In the present review study, the pathogenesis of the virus, the virus immunopathology, the balance between immune responses and oxidative stress are discussed. Also in this review, due to the importance of oxidative stress in the pathogenesis of the disease, some of the most important antioxidant agents whose therapeutic effects have been shown in improving many viral infections, ARDS, and acute lung injury, are recommended to improve the patient’s condition infected with SARS-CoV-2. Besides, the last COVID-19 clinical studies in this field are summarized in this review article. These studies described that melatonin through promoting sleep quality by decreasing vascular permeability, reducing anxiety, and regulating blood pressure; and vitamin C through decreasing the mortality rates and the requirement for mechanical ventilation; and Glutathione through decreasing respiratory distress in the pneumonia of COVID-19 patients; and higher selenium levels could improve the COVID-19 patients' clinical outcomes
similar resources
Return to Sports Activities in athletes with Covid-19 with a Cardiovascular Approach
Introduction: The widespread prevalence of Coronavirus (COVID-19) around the world has raised concerns about physical activity and exercise. Patients with COVID-19 are 22% percent more likely to have heart damage than other people with infectious diseases. Due to the cardiovascular complications seen in patients, there are limitations for athletes due to the severity of the disease. Despite dou...
full textAntioxidant supplements to prevent mortality.
CLINICAL QUESTION Are antioxidant supplements associated with higher or lower all-cause mortality? BOTTOM LINE Antioxidant supplements are not associated with lower all-cause mortality. Beta carotene, vitamin E, and higher doses of vitamin A may be associated with higher all-cause mortality.
full textResponding to Covid-19 — A Once-in-a-Century Pandemic?
SARS-CoV-2 is a highly transmissible respiratory virus causing COVID-19, a disease that has become pandemic. It is the biggest public health concern of this century. The sudden emergence of the novel SARS-CoV-2 has rapidly evolved into a pandemic that posed a serious threat to global health and economy Throughout the COVID-19 pandemic, solving immediate problems and preventing problems are two ...
full textAre Children Less Susceptible To COVID-19? A Case Series
Background The novel coronavirus (SARS-CoV-2 [2019-nCoV]) is the origin of several cases of pneumonia in Wuhan, Hubei province, China. According to the reported data, children are less common to be infected by COVID-19. Besides, their mortality rate is almost zero. Case Presentation In this article, we investigated six childr...
full textAntioxidant supplements and mortality.
To the Editor: Based on their meta-analysis of antioxidant supplementation trials, Dr Bjelakovic and colleagues 1 conclude that some of the intervention nutrients appeared to be associated with increased mortality. Particular aspects of their approach, analysis, and reported findings may have led to incomplete or biased determinations of the real effect of such nutrients in various populations....
full textMy Resources
Journal title
volume 25 issue 2
pages 0- 0
publication date 2022-05
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023